About 50 results
Open links in new tab
  1. January 2025: Notable Drug Approvals - The Cardiology Advisor

    Feb 11, 2025 · The following are some of the notable drug approvals that occurred in January 2025. Omvoh (mirikizumab-mrkz) Humanized immunoglobulin G4 monoclonal antibody that selectively …

  2. Childhood Cancer Treatments May Increase Diabetes Risk

    Feb 25, 2025 · Childhood cancer treatments, specifically total body irradiation, were associated with increased risk of developing diabetes among cancer survivors.

  3. Researchers Quantify the Risk for Diabetes After Gestational Diabetes

    May 16, 2024 · Gestational diabetes is associated with an increased risk for subsequent diabetes, according to a study published online.

  4. Combating Medical Mistrust in the Black Community

    Nov 28, 2023 · Medical mistrust causes barriers to health promotion and prevention, leading to greater health disparities in minority communities.

  5. Association of Black Cardiologists Launches Hypertension Management ...

    Feb 12, 2024 · The Association of Black Cardiologists (ABC) is offering a Hypertension Control Program (HCP) certification for clinicians committed to preventing hypertension and improving hypertension …

  6. Semaglutide Associated With Improved Symptoms in Obesity-Related …

    Apr 26, 2024 · Semaglutide is associated with significant improvement in HF-related symptoms and reductions in body weight in patients with obesity-related HFpEF.

  7. Postdischarge Suicide Prediction Improved With Social Determinants of ...

    Feb 8, 2023 · Machine learning models that predict suicide following VHA psychiatric hospitalization can be improved with clinical notes and health public records.

  8. Apixaban Compared With Dalteparin in Cancer-Related Venous ...

    Jan 10, 2023 · Researchers determined oral apixaban and subcutaneous dalteparin showed similar rates of key outcomes for patients with cancer-related venous thromboembolism.

  9. Venous Thromboembolism Linked to Hospitalization for an Eating …

    May 25, 2023 · Researchers in Japan identified several characteristics that appeared linked to venous thromboembolism in patients hospitalized for an eating disorder.

  10. Mavacamten and Septal Reduction Therapy in Patients With …

    Aug 15, 2022 · Mavacamten reduces the need for septal reduction therapy at 16 weeks among symptomatic patients with obstructive hypertrophic cardiomyopathy.